CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 800 target
Drug / intervention
carboplatin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00003014
NCT00003014Phase 3Completed
CompareCT.gov

Carboplatin in the Adjuvant Treatment of Stage I Seminoma: A Radomized Comparison of Single Agent Carboplatin With Radiotherapy in the Adjuvant Treatment of Stage I Seminoma of the Testis, Following Orchidectomy

Medical Research Council·interventional·Posted Mar 12, 2004·Updated Dec 4, 2013

In Brief

A Phase 3 clinical trial evaluating carboplatin and radiation therapy for Testicular Germ Cell Tumor. Completed, enrolled 800 participants across 62 sites in 7 countries.

Detailed Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known whether chemotherapy is more effective than radiation therapy for testicular cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of carboplatin with that of radiation therapy in treating patients who have stage I testicular cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTesticular Germ Cell Tumor
CountriesBrazil, Canada, Finland, Netherlands, Norway, South Africa, United Kingdom
CollaboratorsEuropean Organisation for Research and Treatment of Cancer - EORTC

Timeline

Phase 3CompletedFinished
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 12, 2004
Enrollment StartApr 1, 1998
Study CompletionJul 1, 2005
TodayJul 2, 2026
Posted 22.3 years ago

Interventions

carboplatindrug

radiation therapyradiation